Pro Chart

Cytek Biosciences Inc.

NasdaqGS: CTKB · Real-Time Price · USD
4.89
+0.11 (2.30%)
At close: Aug 13, 2026, 3:59 PM
4.93
+0.82%
Pre-market: 5:28 AM

Company Description

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Cytek Biosciences Inc.
Cytek Biosciences Inc. logo
CountryUnited States
IPO DateJul 23, 2021
IndustryMedical Devices
SectorHealthcare
Employees682
CEODr. Wenbin Jiang Ph.D.

Contact Details

Address:
47215 Lakeview Blvd
Fremont, CA
United States
Websitehttps://cytekbio.com

Stock Details

Ticker SymbolCTKB
ExchangeNasdaqGS
Fiscal YearJan '25 - Dec '25
Reporting CurrencyUSD
CIK Code0001831915
CUSIP Numbern/a
ISIN Numbern/a
Employer IDn/a
SIC Coden/a

Key Executives

NamePosition
Dr. Wenbin Jiang Ph.D.President, CEO & Chairman of the Board
Mr. William D. McCombeChief Financial Officer
Dr. Ming Yan Ph.D.CTO & Director
Mr. Paul D. GoodsonHead of Investor Relations
Mr. Ilan B. FeuchtwangChief Legal Officer
Mr. Patrik Sebastian JeanmonodHead of Corporate Development Analytics

Latest SEC Filings

No SEC filings available.